These data are consistent with neutrophil changes in the periphery and CNS (Figs. 4 and 6), and suggest that the decreased level of MMP-9 could be one of the mechanisms by which the BR therapy improves stroke outcomes. This evidence concerns the gene MMP9 and Stroke.